November 18, 2016 - By Hazel Jackson · 0 Comments
The stock of Trillium Therapeutics Incorporated (NASDAQ:TRIL) registered an increase of 2.17% in short interest. TRIL’s total short interest was 329,200 shares in November as published by FINRA. Its up 2.17% from 322,200 shares, reported previously. With 60,400 shares average volume, it will take short sellers 6 days to cover their TRIL’s short positions. The short interest to Trillium Therapeutics Incorporated’s float is 5.29%. The stock closed at $8.75 during the last session. It is down 22.36% since April 18, 2016 and is downtrending. It has underperformed by 26.79% the S&P500.
More news for Trillium Therapeutics Inc. (NASDAQ:TRIL) were recently published by: Marketwatch.com, which released: “Trillium Therapeutics Inc.” on August 24, 2009. Etfdailynews.com‘s article titled: “Trillium Therapeutics Inc. (TRIL): Finding The Next Blockbuster Biotech Stock” and published on June 23, 2015 is yet another important article.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
By Hazel Jackson